Results 181 to 190 of about 53,199 (230)

Comparative Efficacy of Belantamab Mafodotin in Combination With Bortezomib and Dexamethasone Versus Standards of Care in Patients With Third-Line or Later Relapsed/Refractory Multiple Myeloma. [PDF]

Am J Hematol
Richter J, Efebera Y, Yimer H, Shukla P, Kapetanakis V, Purser M, Boytsov N, Ballew N.   +7 more
europepmc   +1 more source

Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial. [PDF]

Nat Med
Raab MS, Weinhold N, Kortüm KM, Krönke J, Fenk R, Weisel K, Podola L, Bertsch U, Brobeil A, Mersi J, Huhn S, Arlinghaus R, Hundemer M, Bohl SR, Mai EK, Schub N, Waldschmidt J, Bassermann F, Müller-Tidow C, Heuck C, Sakabedoyan C, Khan J, Ershova E, Koster BD, Engelhardt M, Hänel M, Salwender H, Teipel R, Goldschmidt H, Einsele H, Rasche L, GMMG-HD10/DSMM-XX (MajesTEC-5) investigators.   +31 more
europepmc   +1 more source

Correction: Bortezomib-induced neurotoxicity in human neurons is the consequence of nicotinamide adenine dinucleotide depletion. [PDF]

Dis Model Mech
Snavely AR, Heo K, Petrova V, Szu-Yu Ho T, Huang X, Hermawan C, Kagan R, Deng T, Singeç I, Chen L, Barret LB, Woolf CJ.   +11 more
europepmc   +1 more source

Top advances of the year: Bispecific antibodies in early lines of therapy in multiple myeloma. [PDF]

Cancer
Worth HA, Costa LJ.
europepmc   +1 more source

Real-world investigation of platelet apoptosis for mechanistic insights into severe immune thrombocytopenia and bleeding. [PDF]

Res Pract Thromb Haemost
Tyagi T, Jain K, Matthews M, Halene S, Hwa J, Neparidze N.   +5 more
europepmc   +1 more source

Nanoparticle-Based delivery of proteasome inhibitors for glioblastoma Therapy: Strategies to overcome Blood-Brain barrier and therapeutic resistance. [PDF]

Biochem Pharmacol
Rahman MA, Yadab MK, Apu EH, Ali MM.
europepmc   +1 more source

Real-world efficacy and safety of the carfilzomib-pomalidomide-dexamethasone regimen in patients with relapsed/refractory multiple myeloma: A multicenter retrospective study. [PDF]

Ther Adv Hematol
Fan H, Feng X, Wei R, Zhang X, Li T, Liu L, Wang H, Sun L, Shi X, Zhao H, Li Z, Cui J, Xu J, Ma J, Feng X, Wang W.   +15 more
europepmc   +1 more source

Palbociclib in combination with dexamethasone, bortezomib, and doxorubicin for pediatric relapsed acute lymphoblastic leukemia. [PDF]

Blood Neoplasia
Srinivasan SG, Kamens JL, Marks LJ, Balagtas JMS, Rubnitz JE, Gruber TA.   +5 more
europepmc   +1 more source